Skip to main content
. 2019 Dec 31;16(12):e1003006. doi: 10.1371/journal.pmed.1003006

Table 1. Summary statistics of trial-underrepresented group samples from the Scottish Cancer Registry, 2001–2015.

Characteristic ≥70 years High comorbidity
Total number of patients 9,653 7,965
Total time at risk (years) 56,864 57,094
Median follow-up (years) 5.17 6.53
Number of breast cancer deaths 1,935 740
Number of other deaths 2,018 648
Five-year survival rate 74.7% 87.2%
Median age at diagnosis, years 76 60
Age 76.65 (0.05) 58.75 (0.14)
Tumour size (mm) 24.68 (0.16) 19.79 (0.21)
Inpatient days (in the 5 years prior) 4.99 (0.15) 13.39 (0.45)
PREDICT benefit score 3.02 (0.02) 2.68 (0.04)
Outpatient visits (in the 5 years prior) 7.22 (0.10) 12.68 (0.25)

Data given as mean (SD) unless otherwise indicated. Additional summary statistics available in S1 Table.